223 related articles for article (PubMed ID: 9849983)
1. Management of neonatal candidiasis. Neonatal Candidiasis Study Group.
Rowen JL; Tate JM
Pediatr Infect Dis J; 1998 Nov; 17(11):1007-11. PubMed ID: 9849983
[TBL] [Abstract][Full Text] [Related]
2. High-dose liposomal amphotericin B in the therapy of systemic candidiasis in neonates.
Juster-Reicher A; Flidel-Rimon O; Amitay M; Even-Tov S; Shinwell E; Leibovitz E
Eur J Clin Microbiol Infect Dis; 2003 Oct; 22(10):603-7. PubMed ID: 13680398
[TBL] [Abstract][Full Text] [Related]
3. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
[TBL] [Abstract][Full Text] [Related]
4. Antifungals in systemic neonatal candidiasis.
Frattarelli DA; Reed MD; Giacoia GP; Aranda JV
Drugs; 2004; 64(9):949-68. PubMed ID: 15101785
[TBL] [Abstract][Full Text] [Related]
5. When to suspect fungal infection in neonates: A clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia.
Benjamin DK; Ross K; McKinney RE; Benjamin DK; Auten R; Fisher RG
Pediatrics; 2000 Oct; 106(4):712-8. PubMed ID: 11015513
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study.
Nguyen MH; Peacock JE; Tanner DC; Morris AJ; Nguyen ML; Snydman DR; Wagener MM; Yu VL
Arch Intern Med; 1995 Dec 11-25; 155(22):2429-35. PubMed ID: 7503601
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the incidence, clinical features and outcomes of invasive candidiasis in children and neonates.
Hsu JF; Lai MY; Lee CW; Chu SM; Wu IH; Huang HR; Lee IT; Chiang MC; Fu RH; Tsai MH
BMC Infect Dis; 2018 Apr; 18(1):194. PubMed ID: 29699503
[TBL] [Abstract][Full Text] [Related]
8. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU.
Nolla-Salas J; Sitges-Serra A; León-Gil C; Martínez-González J; León-Regidor MA; Ibáñez-Lucía P; Torres-Rodríguez JM
Intensive Care Med; 1997 Jan; 23(1):23-30. PubMed ID: 9037636
[TBL] [Abstract][Full Text] [Related]
9. A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients.
Abele-Horn M; Kopp A; Sternberg U; Ohly A; Dauber A; Russwurm W; Büchinger W; Nagengast O; Emmerling P
Infection; 1996; 24(6):426-32. PubMed ID: 9007589
[TBL] [Abstract][Full Text] [Related]
10. [Treatment approach for fungal infections in critically ill patients admitted to intensive care units: results of a multicenter survey].
Alvarez-Lerma F; Nolla J; Palomar M; León MA
Enferm Infecc Microbiol Clin; 2003 Feb; 21(2):83-8. PubMed ID: 12586031
[TBL] [Abstract][Full Text] [Related]
11. Experience with caspofungin in the treatment of persistent fungemia in neonates.
Natarajan G; Lulic-Botica M; Rongkavilit C; Pappas A; Bedard M
J Perinatol; 2005 Dec; 25(12):770-7. PubMed ID: 16222348
[TBL] [Abstract][Full Text] [Related]
12. Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group.
Phillips P; Shafran S; Garber G; Rotstein C; Smaill F; Fong I; Salit I; Miller M; Williams K; Conly JM; Singer J; Ioannou S
Eur J Clin Microbiol Infect Dis; 1997 May; 16(5):337-45. PubMed ID: 9228472
[TBL] [Abstract][Full Text] [Related]
13. Neonatal candidosis: clinical picture, management controversies and consensus, and new therapeutic options.
Leibovitz E
J Antimicrob Chemother; 2002 Feb; 49 Suppl 1():69-73. PubMed ID: 11801585
[TBL] [Abstract][Full Text] [Related]
14. Current strategies for treating invasive candidiasis: emphasis on infections in nonneutropenic patients.
Edwards JE; Filler SG
Clin Infect Dis; 1992 Mar; 14 Suppl 1():S106-13. PubMed ID: 1562680
[TBL] [Abstract][Full Text] [Related]
15. Antifungal pharmacotherapy for neonatal candidiasis.
Bliss JM; Wellington M; Gigliotti F
Semin Perinatol; 2003 Oct; 27(5):365-74. PubMed ID: 14626500
[TBL] [Abstract][Full Text] [Related]
16. Persistently positive cultures and outcome in invasive neonatal candidiasis.
Chapman RL; Faix RG
Pediatr Infect Dis J; 2000 Sep; 19(9):822-7. PubMed ID: 11001103
[TBL] [Abstract][Full Text] [Related]
17. The fluconazole era: management of hematogenously disseminated candidiasis in the nonneutropenic patient.
Kramer KM; Skaar DJ; Ackerman BH
Pharmacotherapy; 1997; 17(3):538-48. PubMed ID: 9165556
[TBL] [Abstract][Full Text] [Related]
18. Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study.
Anaissie EJ; Vartivarian SE; Abi-Said D; Uzun O; Pinczowski H; Kontoyiannis DP; Khoury P; Papadakis K; Gardner A; Raad II; Gilbreath J; Bodey GP
Am J Med; 1996 Aug; 101(2):170-6. PubMed ID: 8757357
[TBL] [Abstract][Full Text] [Related]
19. Fluconazole plus amphotericin B combinations are not contraindicated and may add benefit for the treatment of candidemia.
Odds FC
Clin Infect Dis; 2003 May; 36(10):1229-31. PubMed ID: 12746766
[No Abstract] [Full Text] [Related]
20. Comparison of caspofungin and amphotericin B for invasive candidiasis.
Mora-Duarte J; Betts R; Rotstein C; Colombo AL; Thompson-Moya L; Smietana J; Lupinacci R; Sable C; Kartsonis N; Perfect J;
N Engl J Med; 2002 Dec; 347(25):2020-9. PubMed ID: 12490683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
